Clinical effect of 1g/L anthocyanin eye-patch for mild and moderate dry eye
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 5
Abstract
AIM:To evaluate the clinic efficacy of 1g/L anthocyanin eye-patch for mild and moderate dry eye. <p>METHODS: In this prospective and multicenter study, a total of 320 cases(640 eyes)with mild and moderate dry eye were enrolled from 8 Aier Eye Hospitals in Changsha, Chongqing, Wuhan and so on from October 2016 to April 2017. The patients were assigned to eye patch group(160 cases)and artificial tears group(160 cases)based on random number table. The patients in eye-patch group used 1g/L of anthocyanin eye-patch for more than 6h during night sleep, while the patients in artificial tears group used polyvinyl alcohol eye drops for 4 times per day. The evaluation of symptoms and signs were conducted on 1d before the treatment and 14d after the treatment. The evaluation of symptoms adopted the Ocular Surface Disease Index(OSDI), while the observation of signs included tear secretion test(Schirmer Ⅰ test, SⅠt), first noninvasive tear breakup time(NITBUTf)as well as average noninvasive tear breakup time(NITBUTav)measured by Oculus ocular surface analyser. <p>RESULTS: OSDI score, NITBUTf and NITBUTav in the two groups after treatment were significantly improved compared with that before treatment, and the difference had a statistical significance(<i>P</i><0.05). While the difference of SⅠt in the two groups before and after treatment had no statistical significance(<i>P</i>>0.05). There was no significant difference in OSDI score, NITBUTf, NITBUTav and SⅠt between the two groups after treatment(<i>P</i>>0.05).<p>CONCLUSION: The 1g/L anthocyanin eye-patch has similar efficacy with artificial tears for mild and moderate dry eye, which can effectively improve the symptoms and tear film stability.
Authors and Affiliations
Cong-Xiang Wang
Keywords
Related Articles
- EP ID EP656736
- DOI 10.3980/j.issn.1672-5123.2018.5.47
- Views 112
- Downloads 0
Ocular complications of HIV infection
In recent years,with the widespread application of highly effective antiretroviral therapy(HAART), the incidence of human immunodeficiency virus(HIV)and acquired immunodeficiency syndrome(AIDS)related eye complications w...
Efficacy of 23G intra-infusion-assisted scleral buckling on spherical retinal detachment
AIM: To observe the treatment effect and discuss availability of spherical retinal detachment by 23G intra-infusion-assisted scleral buckling. <p>METHODS: Twenty-one eyes were randomly selected from in-patients with rheg...
Effect of intravitreal injection of anti-VEGF on choroidal thickness and blood flow in posterior ciliary artery in patients with wet ARMD
AIM:To investigate the effect of intravitreal injection of anti-vascular endothelial growth factor(VEGF)on choroidal thickness and posterior ciliary artery blood flow in patients with wet age-related macular degeneration...
Analysis on Bevacizumab with PDT for CSC
AIM: To study the influence of intravitreal injection of bevacizumab combined with photon dynamic treatment(PDT)in the treatment of central serous choroiretinopathy(CSC). <p>METHODS:We selected 82 CSC patients treated in...
Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
AIM: To compare the efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration. <p>METHODS: Totally 78 cases(78 eyes)of wet age-related macular degeneration treated in our hospital from February...